admin Share This! FacebookTwitterPinterestLinkedIn Investing News Syringe Maker Catalent Anticipates Boost From Demand for Injectable Weight-Loss Drugs November 15, 202378 Views1 Min Read Syringe maker Catalent said it expects to benefit from soaring demand for injectable weight-loss drugs, and shares surged. You may also like Investing News How We Review and Rate Personal Loan Lenders 4 hours ago Investing News 3 Best Vanguard Target Retirement Funds 7 hours ago Investing News Processed food stocks fall as investors brace for increased scrutiny under Trump, RFK Jr. 7 hours ago Ackman’s Pershing Square Nearly Doubles Stake in Alphabet’s Class A Shares Wells Fargo Savings Account Interest Rates: November 2023 Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us
Investing News Processed food stocks fall as investors brace for increased scrutiny under Trump, RFK Jr. 7 hours ago